CBER Implements Pre-Clinical Meeting Program For Biologics, Gene Therapy Sponsors

INTERACT program will allow sponsors to ask FDA questions about manufacturing and other technical issues to help streamline development.

LI-2 Protein_564977620_1200.jpg

More from US FDA

More from Agency Leadership